<DOC>
	<DOCNO>NCT01907763</DOCNO>
	<brief_summary>The objective study assess efficacy safety SOTB07 asthma patient observe change FEV1 ( % predict ) primary efficacy endpoint oral administration SOTB07 200mg , 400mg , placebo 12 week .</brief_summary>
	<brief_title>Study Phase III Study Assess Efficacy Safety SOTB07 Asthma Patients</brief_title>
	<detailed_description>A 12-week , Multi-center , Randomized , Double blind , Parallel group , Placebo-controlled study Assess Efficacy Safety SOTB07 asthma patient</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Male eligible female subject age 15 year 2 . A female eligible : Nonchild bear potential ( i.e. , physiologically incapable become pregnant ) , include female least 2 year post menopausal Child bear potential agrees acceptable contraceptive method use consistently correctly Negative pregnancy test screen 3 . Nonsmoker least 1 year , pack history ≤ 10 pack year 4 . Symptom persistent asthma , define National Institute Health ( NIH ) 5.50 % ≤ FEV1 ≤ 80 % predict screening visit ( withhold inhale , short act ßagonist 6 hour ) 6.FEV1 reversibility ≥ 12 % 200 ml 2030 minute inhalation short act ßagonist ( Salbutamol 2 puff ; 200㎍ ) Visit 1 within 6 month Visit 1 7.Capable withholding salbutamol use ≥ 6 hour prior clinic visit 8.Appropriately sign date informed consent obtain 1 . Active upper low respiratory tract infection within 3 week visit 1 2 . Emergency room treatment asthma within 1 month hospitalization asthma within 3 month visit 1 3 . Any evidence infectious , oncologic , active pulmonary disease obtain chest radiography within 12 month visit 1 4 . Clinically significant , opinion investigator , hematological , liver , renal , heart , neurological disease , serious disease 5 . Hypersensitivity β2agonist , sympathomimetic drug , leukotriene receptor antagonist Sophora tonkinensis Radix Rhizoma 6 . Clinically significant uncontrolled psychiatric disease 7. history drug alcohol abuse 8 . Inhaled , oral parenteral corticosteroid within 4 week visit 1 9 . Change Immunotherapy within 6 month visit 1 10 . Administration antiasthma agent within 1 week visit 1 11 . Administration medication may affect course asthma , interact sympathomimetic amine 12 . Participation study use experimental medication within 1 month visit 1 13 . Other ineligible subject opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>SOTB07</keyword>
</DOC>